Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Breast Neoplasms 77Carcinoma, Non-Small-Cell Lung 64Lung Neoplasms 31Hodgkin Disease 13Lymphoma 11Neoplasm Metastasis 10Recurrence 8Lymphoma, Non-Hodgkin 8Prostatic Neoplasms 7Neoplasms 7Adenocarcinoma of Lung 7Uterine Cervical Neoplasms 5Sarcoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Mesothelioma, Malignant 4Lymphoma, Large B-Cell, Diffuse 4Breast Neoplasms, Male 4Triple Negative Breast Neoplasms 3Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Burkitt Lymphoma 3Brain Neoplasms 3Waldenstrom Macroglobulinemia 2

Interventions

Ipilimumab 114pembrolizumab 95Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Melanoma × Vinorelbine × Clear all
NCT00256282 2018-05-03

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

University of California, Irvine

Phase 2 Completed
52 enrolled 8 charts
Dermatologic

Melanoma

NCT00003828 2012-08-22

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

SWOG Cancer Research Network

Phase 2 Completed
24 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡